Liberty Health Sciences opens Port St. Lucie’s first medical cannabis dispensary
Port St. Lucie Cannabis Education Center is Liberty’s fourth CEC to open in Florida in five months
TORONTO, May 31, 2018 /PRNewswire/ – Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) (“Liberty” or the “Company”) today announced the opening of its Cannabis Education Center (“CEC”) in Port St. Lucie, Florida. This is Liberty’s fourth CEC to open in the state this year and advances the Company’s mission to provide Florida’s residents with convenient access to high-quality medical cannabis and patient-focused educational resources. Liberty’s CEC is the first medical cannabis dispensary to open in Port St. Lucie, which is home to approximately 185,000 residents.
Liberty is proud to open Port St. Lucie’s first dispensary as we continue to expand our network of patient-centric Cannabis Education Centers throughout Florida. This is our fourth CEC to open its doors within the last five months, reflecting Liberty’s commitment to advance our aggressive growth strategy to serve all of Florida’s patients in need.
George Scorsis, Director and CEO of Liberty
The Port St. Lucie location is ideally situated to provide patients in the area with convenient access to our expanding portfolio of high-quality brands and products and the dedicated support of our Patient Care team.
Liberty’s Cannabis Education Centers go above and beyond to recognize and treat the unique needs of each individual, ensuring a positive and productive patient experience. Every CEC provides exceptional patient care through a comprehensive platform that includes educational tools and resources and compassionate one-on-one consultations geared towards informing patients on medical cannabis use.
All of Liberty’s CEC locations will offer a wide array of brands such as Aphria, Solei, Mary’s Medicinals, incredibles and Isodiol. These products aim to provide patients with a variety of high-quality options to meet their needs across all state-approved methods of cannabis consumption, including vapes, oils, tinctures and capsules.
As Liberty continues to aggressively pursue opportunities in the Florida and Massachusetts markets, the Company has announced that it will no longer proceed with the acquisition of Aphria Inc.’s minority membership interests in Copperstate Farms, LLC and Copperstate Farms Investors, LLC (collectively “Copperstate”) as previously announced on February 2, 2018. The existing investors in Copperstate have exercised their right of first refusal to purchase the minority interests in Copperstate on the same terms as previously announced.
About Liberty Health Sciences Inc.
Liberty Health Sciences Inc. is an investor and operator in the medical cannabis market, capitalizing on new and existing opportunities in U.S. states where medical cannabis is legal. Liberty’s stringent investment criteria for expansion maximizes returns to shareholders, while focusing on significant near- and mid-term opportunities. Liberty has an extensive background in highly regulated industries, with expertise in becoming a low-cost producer. Liberty leverages commercial greenhouse knowledge to deliver high-quality, clean and safe pharmaceutical grade cannabis to patients.
For more information, please visit libertyhealthsciences.com